About us
Our company
Who we are
We are the pioneers of Model-based Pulse Wave Analysis!
2015: The beginning of our research in the field of Pulse Wave Analysis.
2017: After intensive project work, we were able to recreate an originally analog, hand-wired artery model for the first time using special software. This modified model can simulate human pulse waves faithfully.
2018: The year of our decisive breakthrough: we adapted the model to reproduce any subject’s specific pulse wave curves: The birth of Model-based Pulse Wave Analysis (mbPWA) and our patent-pending vascular avatar.
2019: Based on our continued research and the latest medical knowledge gained throughout many measurement series, we introduced the novel cardiac parameter LVPT (Left Ventricular Plateau Time). This specific parameter defines various diagnostically highly interesting cardiac preloads in our arterial model.
2021: The past year marks the beginning of our measurement projects at several German dialysis stations. The aim is to validate LVPT as a parameter of volume status in dialysis patients, as it has crucial informative value for the cardiac risk profile of this patient group.
2022: Since the beginning of this year, we have been conducting in-depth studies to optimize the dry weight of dialysis patients: For this purpose, we are validating various parameters in the arterial model for the early detection of cardiac insufficiencies and atherosclerosis. Another goal is the metrological objectification of cardiac risks associated with stress.
2023: Product launch of the Erkameter 133, the successor of the VascAssist 2, which already drew on Model-based Pulse Wave Analysis. We developed the new device in cooperation with ERKA, Bad Tölz.
